ESKAYEF PHARAMCEUTICALS LIMITED

Company Introduction: ESKAYEF PHARMACEUTICALS LIMITED

Company Type: Manufacturer (Factory)

ESKAYEF PHARMACEUTICALS LIMITED is one of the leading and most respected pharmaceutical companies in Bangladesh. It is a proud member of the Transcom Group, a prominent business conglomerate in the country.

The company is primarily a manufacturer, operating state-of-the-art production facilities that adhere to current Good Manufacturing Practices (cGMP) and international quality standards. ESKAYEF is renowned for its commitment to producing high-quality, safe, and effective medicines.

Key details about ESKAYEF PHARMACEUTICALS LIMITED:

Establishment: The company was established in 1990, building upon the legacy of SmithKline & French (SK&F) in Bangladesh, whose operations were acquired by Transcom Group.

Product Portfolio: ESKAYEF manufactures a comprehensive range of pharmaceutical products across various therapeutic categories. These include, but are not limited to, antibiotics, gastrointestinal drugs, cardiovascular medications, anti-diabetics, central nervous system (CNS) products, respiratory medicines, vitamins, and minerals.

Dosage Forms: Their product range encompasses a wide array of dosage forms such as tablets, capsules, oral liquids, injectables, dry powder suspensions, nasal sprays, and ophthalmic preparations.

Quality and Compliance: The company places a strong emphasis on quality assurance and control, ensuring that all products meet stringent national and international regulatory requirements.

Market Presence: ESKAYEF PHARMACEUTICALS LIMITED holds a significant share in the domestic pharmaceutical market of Bangladesh and is also actively involved in exporting its products to various countries globally, demonstrating its commitment to international standards and reach.

Overall, ESKAYEF PHARMACEUTICALS LIMITED is a well-established pharmaceutical manufacturer dedicated to improving healthcare outcomes through its innovative and high-quality medicinal products.

ESKAYEF PHARMACEUTICALS LIMITED of Bangladesh manufactures and sells a comprehensive range of pharmaceutical products. These include antibiotics such as Azithromycin, Cefixime, and Ciprofloxacin; antidiabetic medications like Metformin, Gliclazide, and Vildagliptin; and cardiovascular drugs including Atorvastatin, Amlodipine, and Telmisartan. Their product portfolio also covers gastrointestinal treatments such as Omeprazole, Pantoprazole, and Domperidone; respiratory medicines like Montelukast, Salbutamol, and Fexofenadine; and central nervous system products such as Escitalopram and Alprazolam. Furthermore, they offer pain management and anti-inflammatory drugs including Paracetamol, Ibuprofen, and Diclofenac; various vitamins and mineral supplements; dermatological preparations; and oncology products. The company also produces medicines for other therapeutic areas such as antifungals, antivirals, urologicals, and women's health.